SUMITOMO PHARMA CO. LTD.SUMITOMO PHARMA CO. LTD.SUMITOMO PHARMA CO. LTD.

SUMITOMO PHARMA CO. LTD.

No trades
See on Supercharts

Price target

3.350.000.00%
The 7 analysts offering 1 year price forecasts for DPM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to DPM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


DPM EPS for the last quarter is −0.76 EUR despite the estimation of 0.11 EUR. In the next quarter EPS is expected to reach 0.25 EUR. Track more of SUMITOMO PHARMA CO. LTD. financials and stay on top of what is up with the company.
In the next quarter SUMITOMO PHARMA CO. LTD. revenue is expected to reach ‪554.50 M‬ EUR. Check out SUMITOMO PHARMA CO. LTD. revenue and earnings and make informed decisions.
According to analysts, DPM price target is 3.35 EUR with a max estimate of 4.53 EUR and a min estimate of 2.24 EUR. Check if this forecast comes true in a year, meanwhile watch SUMITOMO PHARMA CO. LTD. stock price chart and keep track of the current situation with DPM news and stock market news.
We've gathered opinions of 7 analysts rating DPM stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as sell. Note that it's not a trading advice — your own analysis is still required.